Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma

J Am Acad Dermatol. 2010 Feb;62(2):300-7. doi: 10.1016/j.jaad.2009.02.035. Epub 2009 Nov 26.

Abstract

Cutaneous T-cell lymphomas most commonly have a CD4(+) memory T-cell phenotype with relatively indolent course, but may in rare cases present with a CD8(+) cytotoxic phenotype exhibiting strikingly more aggressive clinical behavior. We present two cases of the clinically aggressive subtype of primary cutaneous epidermotropic CD8(+) cutaneous T-cell lymphoma and review the current literature, clinical behavior, and recommendations for treatment distinct from that of more common CD4(+) variants of cutaneous T-cell lymphoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bexarotene
  • CD8-Positive T-Lymphocytes / immunology*
  • Combined Modality Therapy
  • Humans
  • Lymphoma, T-Cell, Cutaneous / immunology*
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Lymphoma, T-Cell, Cutaneous / therapy
  • Male
  • Skin / immunology
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy
  • Tetrahydronaphthalenes / therapeutic use

Substances

  • Tetrahydronaphthalenes
  • Bexarotene